© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Top Medical News
COVID-19 Stressors Associated With Poorer Mental Health in Parkinson Disease
September 17, 2021
By Abby Reinhard
Data from the PRIME-NL study showed stressors resulting from the pandemic impacted depression, anxiety, and quality of life.
NeurologyLive Friday 5 — September 17, 2021
September 17, 2021
By NeurologyLive Staff
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 17, 2021.
Opicapone Demonstrates Small Benefit for Sleep in Parkinson Disease
September 17, 2021
By Marco Meglio
Improvements in mean total amount of time and percentage of participants that were awake suggested limited effect with opicapone (Ogentys; Neurocrine Bio).
ND0612 Subcutaneous Levodopa Delivery System Demonstrates Efficacy in Phase 2 Setting
September 17, 2021
By Marco Meglio
Patients with Parkinson disease in both the 24-hour and 16-hour ND0612 dosing regimen groups had ON-state UPDRS-motor scores and UPDRS-ADL scores improve over the 12-month period.
Trends in Migraine: COVID’s Impact and Barriers to Treatment
September 16, 2021
By Matt Hoffman
Deena Kuruvilla, MD, director, Westport Headache Institute, offered her insight into the trends in the clinical care of migraine and the effect that the pandemic has had on patients.
